Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > USA. G. Brand TrastuzuMAb > Approved Indications> > >+PacliTaxel>

---

first line treatment of Human Epidermal growth factor Receptor 2-positive (HER2+) metastatic breast cancer


>+PacliTaxel>'s products
This section has no products